137 related articles for article (PubMed ID: 476594)
1. Adjuvant chemotherapy of breast cancer.
Cooper RG; Holland JF; Glidewell O
Cancer; 1979 Sep; 44(3):793-8. PubMed ID: 476594
[TBL] [Abstract][Full Text] [Related]
2. 5-drug adjuvant chemotherapy for breast cancer.
Carey RW; Sohier WD; Kaufman S; Weitzman SA; Kelley RM; Lew RA; Halpern E
Cancer; 1979 Jul; 44(1):35-41. PubMed ID: 455262
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
4. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
Holland JF; Glidewell O; Cooper RG
Surg Gynecol Obstet; 1980 Jun; 150(6):817-21. PubMed ID: 7376042
[TBL] [Abstract][Full Text] [Related]
5. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
6. Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Mehta RR; McDermott JH; Hieken TJ; Marler KC; Patel MK; Wild LD; Das Gupta TK
J Clin Oncol; 1998 Jul; 16(7):2409-16. PubMed ID: 9667258
[TBL] [Abstract][Full Text] [Related]
7. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.
Manni A; Trujillo JE; Pearson OH
Cancer Treat Rep; 1980 Jan; 64(1):111-6. PubMed ID: 6155207
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
[TBL] [Abstract][Full Text] [Related]
9. One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
Rivkin SE; Green S; Metch B; Jewell WR; Costanzi JJ; Altman SJ; Minton JP; O'Bryan RM; Osborne CK
J Clin Oncol; 1993 Sep; 11(9):1710-6. PubMed ID: 8355037
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
[TBL] [Abstract][Full Text] [Related]
11. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
Hirshaut Y; Kesselheim H
Cancer; 1983 Jun; 51(11):1998-2004. PubMed ID: 6687698
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Rivkin SE; Green S; Metch B; Glucksberg H; Gad-el-Mawla N; Constanzi JJ; Hoogstraten B; Athens J; Maloney T; Osborne CK
J Clin Oncol; 1989 Sep; 7(9):1229-38. PubMed ID: 2671283
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy in disseminated carcinoma of the breast.
Kaufman S; Goldstein M
Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
[No Abstract] [Full Text] [Related]
15. Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Rivkin SE; Green S; Metch B; Cruz AB; Abeloff MD; Jewell WR; Costanzi JJ; Farrar WB; Minton JP; Osborne CK
J Clin Oncol; 1994 Oct; 12(10):2078-85. PubMed ID: 7931477
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
18. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
19. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
[TBL] [Abstract][Full Text] [Related]
20. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]